Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
Volume 0.22M
Average 0.35M
RNA Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Atrium Therapeutics, Inc.NASDAQ: RNA
Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026
Change in working capital of -$27.72M in Q1 FY2026
Q1 FY2026 change in working capital was -$27.72M.
Context
- Change in working capital amounted to 1.1% of revenue in FY2025.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- (200K) USD
- Year-over-year change
- —
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (200K) | — |
Change in Working Capital vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Change in Working Capital figures are available to compare.
Cash Flow Statement
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.